Although more older women receive breast-conserving therapy, gaps in treatment exist

	Tweet

According to a new study published in the October issue of the Journal of the American College of Surgeons, although breast-conserving surgery (BCS), commonly known as lumpectomy, is increasingly being used to treat older women with nonmetastatic invasive breast cancer, there are still significant socioeconomic and geographic disparities in the use of this type of therapy. For example, women in the Northeast and Pacific West are significantly more likely to receive BCS than those in the South and parts of the Midwest.

In BCS, only a part of the affected breast is removed, whereas a mastectomy involves removing all of the breast tissue, sometimes along with other nearby tissues. Combined with radiotherapy, BCS is as effective as a mastectomy for treatment of early invasive breast cancer. Yet despite the large body of evidence supporting the efficacy of BCS, studies conducted in the last two decades reported that less than half of all surgically treated patients with nonmetastatic invasive disease received BCS.

“Treatment of nonmetastatic invasive breast cancer has improved significantly over the past several decades, but we continue to fall short of the goal to treat every woman with the highest quality care,” said Grace L. Smith, MD, PhD, Postdoctoral Fellow, Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center. “Our study suggests that barriers exist that may prevent many women with breast cancer – especially those in poorer areas, areas with low education levels, rural communities and counties with few radiation oncologists – from being offered every treatment option that should be available to them.”

Using a national Medicare database, researchers identified women age 65 years and older who were surgically treated in 2003 for invasive breast cancer. Claims codes identified demographic, treatment and geographic region covariates. The 2003 Area Resource File provided socioeconomic data.

Of 56,725 women in the database, 59 percent were treated with BCS versus 41 percent with mastectomy. BCS was more widely used in women who were younger than 70 years (odds ratio [OR], 1.37; p<0.001) and had lymph node-negative disease (OR, 1.60; p<0.001). The results showed that socioeconomic and demographic factors influenced the type of surgical procedure, with BCS more prevalent in areas with low poverty (OR, 1.05; p=0.03), high education (OR, 1.13; p<0.001) or a high density of radiation oncologists (OR, 1.30; p=0.01), and in metropolitan areas (OR, 1.20; p<0.001). Results also revealed disparities between geographic regions. Patients in the Northeast and Pacific West were the most likely to undergo BCS (around 79 percent and 71 percent, respectively), while patients in the South and portions of the Midwest were the least likely (57 to 59 percent and 58 percent, respectively).

###

About the American College of Surgeons

The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and to improve the care of the surgical patient. The College is dedicated to the ethical and competent practice of surgery. Its achievements have significantly influenced the course of scientific surgery in America and have established it as an important advocate for all surgical patients. The College has more than 74,000 members and is the largest organization of surgeons in the world.

Contact: Sally Garneski

312-202-5409
Weber Shandwick Worldwide

RELATED STORIES:
Painkiller can boost breast cancer survival rates   Breast Cancer Surgery Preserves Artery for Future Heart Surgery   Annual screening with breast ultrasound or MRI could benefit some women   Just a few drinks a week tied to breast cancer   Migraines Associated with Lower Risk of Breast Cancer   Analysis of breast-cancer gene role offers promising target   Nanotube Therapy Takes Aim at Breast Cancer Stem Cells   Yoga provides emotional benefits to women with breast cancer   Shortening radiotherapy feasible for breast cancer   Integrating genetic information with breast cancer risk factors may help refine prognosis   France to offer surgery if breast implants a risk   3-week radiation therapy as effective as 5 weeks for early-stage breast cancer   FDA Panel OKs Ultrasound to Screen Dense Breasts   Fertility drugs don’t raise breast cancer risk   City-dwelling women at greater risk for breast cancer   New way to predict cancer returning?   Stress about wife’s breast cancer can harm a man’s health   Physicians validate reclassification of breast cancer stages   Even a little drinking may raise breast cancer risk: study   Breast reconstruction may not boost well-being   Glaxo drug slows breast cancer in study   Drop in U.S. mammography rate worries cancer experts

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]